PATISIRAN vs PEGCETACOPLAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PATISIRAN vs PEGCETACOPLAN: Safety Overview
| Metric | PATISIRAN | PEGCETACOPLAN |
|---|---|---|
| Total FAERS Reports | 2,708 | 1,369 |
| Deaths Reported | 384 | 84 |
| Death Rate | 14.2% | 6.1% |
| Hospitalizations | 1,050 | 252 |
| Average Patient Age | 65.6 yrs | 65.4 yrs |
| % Female Patients | 34.2% | 70.5% |
| FDA Approval Date | Aug 10, 2018 | Feb 17, 2023 |
| Manufacturer | Alnylam Pharmaceuticals, Inc. | Apellis Pharmaceuticals, Inc. |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |